Genetic basis for clinical expression in multiple sclerosis
The Multiple Sclerosis Genetics Group, Stephen L. Hauser(University of California, San Francisco), Jonathan L. Haines(Vanderbilt University), A. J. Green(University of California, San Francisco), Patricia Bucher(University of California, San Francisco), Margaret A. Pericak‐Vance(University of Miami), Lisa F. Barcellos(University of California, San Francisco), Jorge R. Oksenberg(University of California, San Francisco), Jacqueline Rimmler(Duke Medical Center), Silke Schmidt(München Klinik), M. Garcia(Vanderbilt University), Robin Lincoln(University of California, San Francisco)
Cited by 155
Related Papers
Finding the missing heritability of complex diseases
|Nature|2009|8.5k
Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration
|Science|2005|2.4k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
|New England Journal of Medicine|2016|1.9k